[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593024":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":36,"responsibleParty":155,"collaborators":20,"id":157,"slug":158,"hasResults":159,"nctId":160,"briefTitle":161,"officialTitle":161,"acronym":162,"eligibilityCriteria":163,"healthyVolunteers":159,"sex":164,"minAge":165,"maxAge":20,"enrollmentInfo":166,"targetDuration":20,"studyType":169,"phases":170,"briefSummary":172,"conditions":173,"keywords":175,"overallStatus":69,"whyStopped":20,"lastUpdateSubmitDate":179,"lastUpdatePostDateStruct":180,"startDateStruct":183,"completionDateStruct":185,"leadSponsor":187,"locationsCount":188},{"fullName":5,"class":6},"Hôpital NOVO","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Orbital ultrasounds","EXPERIMENTAL","Orbital ultrasounds on patients suspected of GCA at the enrollment (M0) and at 6 months if the suspicion of GCA is confirmed after all the tests realized at the enrollment.",[13],"Diagnostic Test: orbital ultrasound",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIAGNOSTIC_TEST","orbital ultrasound","orbital ultrasound at the beginning of the participation, and at 6 months after the inclusion.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Omar AL TABAA, Dr","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Maryline DELATTRE","CONTACT","+330130754131","maryline.delattre@ght-novo.fr",{"name":32,"role":28,"phone":33,"phoneExt":34,"email":35},"Mathilde WLODARCZYK","+330130754040","7199","mathilde.wlodarczyk@ght-novo.fr",[37,54,67,81,94,107,120,130,142],{"facility":38,"status":39,"city":40,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Rhumatology departement - Centre Hospitalier Aix en Provence","NOT_YET_RECRUITING","Aix-en-Provence","France","FR",{"type":44,"coordinates":45},"Point",[46,47],5.44973,43.5283,{"lat":47,"lon":46},[50],{"name":51,"role":28,"phone":52,"phoneExt":20,"email":53},"François VIDAL, Dr","+33442335049","fvidal@ch-aix.fr",{"facility":55,"status":39,"city":56,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Rhumatology department - Centre Hospitalier Universitaire de Brest","Brest",{"type":44,"coordinates":58},[59,60],-4.48628,48.39029,{"lat":60,"lon":59},[63],{"name":64,"role":28,"phone":65,"phoneExt":20,"email":66},"Baptiste QUERE, Dr","+33 2 98 22 33 33","baptiste.quere@chu-brest.fr",{"facility":68,"status":69,"city":70,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Internal Medecine Department- CHU Caen","RECRUITING","Caen",{"type":44,"coordinates":72},[73,74],-0.35912,49.18585,{"lat":74,"lon":73},[77],{"name":78,"role":28,"phone":79,"phoneExt":20,"email":80},"Jonathan BOUTEMY, Dr","+33231064579","boutemy-j@chu-caen.fr",{"facility":82,"status":39,"city":83,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":84,"geoPoint":88,"contacts":89},"Internal Medicine and Clinical Immulogy department - Centre Hospitalier Universitaire de Dijon","Dijon",{"type":44,"coordinates":85},[86,87],5.01391,47.31344,{"lat":87,"lon":86},[90],{"name":91,"role":28,"phone":92,"phoneExt":20,"email":93},"Maxime SAMSON, Dr","+33 3 80 29 34 32","maxime.samson@chu-dijon.fr",{"facility":95,"status":39,"city":96,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Internal Medicine and VascularMedecine Department - Centre Hospitalier Universitaire de Nantes","Nantes",{"type":44,"coordinates":98},[99,100],-1.55336,47.21725,{"lat":100,"lon":99},[103],{"name":104,"role":28,"phone":105,"phoneExt":20,"email":106},"Olivier ESPITIA, Dr","+33 2 40 08 33 55","Olivier.ESPITIA@chu-nantes.fr",{"facility":108,"status":39,"city":109,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":110,"geoPoint":114,"contacts":115},"Internal Medicine department - Hôpital Saint-Antoine","Paris",{"type":44,"coordinates":111},[112,113],2.3488,48.85341,{"lat":113,"lon":112},[116],{"name":117,"role":28,"phone":118,"phoneExt":20,"email":119},"Etienne GHRENASSIA, Dr","+33 1 71 97 05 06","etienne.ghrenassia@aphp.fr",{"facility":121,"status":39,"city":109,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":122,"geoPoint":124,"contacts":125},"Rhumatology department - Hôpital Bichat",{"type":44,"coordinates":123},[112,113],{"lat":113,"lon":112},[126],{"name":127,"role":28,"phone":128,"phoneExt":20,"email":129},"Sébastien OTTAVIANI, Dr","+33 1 40 25 70 27","sebastien.ottaviani@aphp.fr",{"facility":131,"status":39,"city":132,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":133,"geoPoint":137,"contacts":138},"Rhumatology department - Hôpital NOVO - Pontoise site","Pontoise",{"type":44,"coordinates":134},[135,136],2.1,49.05,{"lat":136,"lon":135},[139],{"name":23,"role":28,"phone":140,"phoneExt":20,"email":141},"+33130755226","omar.altabaa@ght-novo.fr",{"facility":143,"status":39,"city":144,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Rhumatology department - Centre Hospitalier Universitaire de Tours","Tours",{"type":44,"coordinates":146},[147,148],0.70398,47.39484,{"lat":148,"lon":147},[151],{"name":152,"role":28,"phone":153,"phoneExt":20,"email":154},"Guillaume CARVAJAL, Dr","+33 2 47 47 47 47","guillermo.carvajal@univ-tours.fr",{"type":156,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100593024","optic-nerve-sheath-evaluation-in-giant-cell-artheritis-by-ultrasound-100593024",false,"NCT07001059","oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound","PETRUS","Inclusion Criteria:\n\n* Patient with suspected GCA\n* Patient over 50 years\n\nExclusion Criteria:\n\n* Patient with history of GCA\n* Patient with a history of polymyalgia rheumatic (PMR) without initial PET scan\n* Patient with a history of retinal disease, demyelinating disease, or intracranial hypertension\n* Use of corticosteroids \\> 0.5mg\u002Fkg in the last 2 weeks","ALL","50 Years",{"count":167,"type":168},190,"ESTIMATED","INTERVENTIONAL",[171],"NA","The purpose of this study is to evaluate whether the measure of the optic nerve sheath is a reliable diagnostic marker for giant cell arteritis",[174],"Giant Cell Arteritis (GCA)",[176,177,178],"Giant Cell Arteritis","Optic nerve sheath","Ultrasound","2025-09-08",{"date":181,"type":182},"2025-09-12","ACTUAL",{"date":184,"type":182},"2025-09-04",{"date":186,"type":168},"2028-03-31",{"name":5,"class":6},9]